Rapid Nutrition PLC appoints Bowsprit Partners as Euronext Listing Sponsor

30 Jun 2026 04:50 CEST

Rapid Nutrition PLC appoints Bowsprit Partners as Euronext Listing Sponsor

Experienced pan-European capital markets adviser appointed to support Rapid Nutrition's continued growth and investor engagement.

London, United Kingdom – 29 June, 2026 – Rapid Nutrition PLC (Euronext Growth: ALRPD), a global HealthTech and wellness company focused on evidence-based nutrition, today announces the appointment of Bowsprit Partners Limited ("Bowsprit Partners") as its new Euronext Listing Sponsor. 

Bowsprit Partners is a corporate finance and corporate broking firm specialising in advising both growing public and private companies, with a strong focus on cross-border equity capital markets transactions. In addition to being an authorised Listing Sponsor for the Euronext Growth and Access Markets in Paris, Brussels, Lisbon, and Dublin, Bowsprit Partners is a Member Firm of the London Stock Exchange and holds multiple accreditations including, Certified Adviser for the Nasdaq First North Growth Market in Stockholm, AQSE Corporate Adviser for the Aquis Stock Exchange, Euronext Growth Advisor for Euronext Growth Oslo and US OTC Markets Sponsor for international companies.

About Rapid Nutrition

Rapid Nutrition PLC is a global HealthTech company advancing wellness through evidence-based, personalized nutrition solutions. By leveraging artificial intelligence, advanced technologies, and clinical research, the company delivers products and programs designed to optimize nutrition, improve health outcomes, and promote sustainable, healthier lifestyles worldwide.

Investor Relations Contact:

ir@rnplc.com

Investor Access 
+1 (855) 77-ALRPD

Bowsprit Partners Limited (Listing Sponsor) 

+44 (0)203 883 4430

Disclaimer

This announcement contains forward-looking statements, including statements regarding the Company’s expectations, intentions, plans, beliefs or forecasts. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or developments to differ materially from those expressed or implied by such statements. These forward-looking statements are based on assumptions and assessments made by the Company in light of its experience and perception of historical trends, current conditions and expected future developments. Forward-looking statements speak only as at the date of this announcement.

Except as required by applicable law or regulation, Rapid Nutrition PLC undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are provided for illustrative purposes only and are not guarantees of future performance.

This announcement is for information purposes only and does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities of Rapid Nutrition PLC in any jurisdiction. This announcement does not constitute a prospectus, offering memorandum or admission document for the purposes of the UK prospectus regime, Regulation (EU) 2017/1129 (the “Prospectus Regulation”), the U.S. Securities Act of 1933 (as amended), or the rules of any securities exchange or trading venue.

The distribution of this announcement may be restricted by law in certain jurisdictions. Persons into whose possession this announcement comes are required to inform themselves about, and to observe, any such restrictions. Any failure to comply with such restrictions may constitute a violation of applicable securities laws.